Event Type
Disclosure
Mandatory
Variant
8-K
. Entry into a Material Definitive Agreement On December 16, 2025, Humacyte, Inc. (the “Company”) entered into a Sales Agreement (the “Agreement”) with TD Secur
. Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 5.1 Opinion of Covington & Burling LLP. 10.1* Sales Agreement, dated as of Decembe